Abstract
Inorganic Complexes are widely used in pharmaceutical industry. Especially chelating complexes are used as the scavengers of heavy metal ions. This present study is aimed to synthesis ethylenediamine and its derivative Zn (II) complexes, and identifies the biological efficiency of the complexes. The 1H NMR spectra of ligands and Zn complexes are confirming the complexation. Downfield shifts of complexes further support the complexation. All the complexes are well crystalline and the average particle size is 80. The calculated percentage of an element in all the complexes is well agreed with the percentage of elements obtained from the CHNS analyzer. Applications of the complexes are studied by its Invitro Anti-diabetic activity. [Zn(pren)2]2+complex exhibits greater percentage inhibition (63.57%). The homo catenation of the ligand is response to increase the drug efficiency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.